Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zynerba Pharma CS (NQ: ZYNE ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.300 (10) Ask (Size) 1.370 (10) Prev. Close 1.300 Today's Range N/A - N/A 52wk Range 1.240 - 1.290 Shares Outstanding 53,939,431 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Shares of Harmony Bioscience Are Falling on Friday October 13, 2023 The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia. Via The Motley Fool New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies October 11, 2023 Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc. Via Benzinga Performance More News Read More Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions October 04, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023 September 29, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023 September 26, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For September 18, 2023 September 18, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium September 14, 2023 From Zynerba Pharmaceuticals, Inc. Via GlobeNewswire ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE September 05, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. August 24, 2023 From Brodsky & Smith LLC Via GlobeNewswire Cannabis Stock Movers For August 18, 2023 August 18, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 August 16, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 16, 2023 August 16, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Occidental Petroleum To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Wednesday August 16, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 August 15, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID) August 14, 2023 From Brodsky & Smith LLC Via GlobeNewswire Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher August 14, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today? August 14, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Intraday Session August 14, 2023 Via Benzinga Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 14, 2023 Via Benzinga US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet August 14, 2023 Via Benzinga Topics Stocks Exposures US Equities Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals August 14, 2023 Via Benzinga Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today? August 14, 2023 Via Benzinga Dow Falls 50 Points; Monday.com Posts Upbeat Results August 14, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.